We are live on ! Find out more
NYMX

Nymox Pharmaceutical Corp
NYMX

Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

1 hedge funds and large institutions have $4.21K invested in Nymox Pharmaceutical Corp in 2026 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more capital invested

Capital invested by funds: $2.46K → $4.21K (+$1.75K)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

NYMX Hedge Fund Activity: Q2 2026 in Review

1 of the 8,332 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q2 2026, worth a combined $4.21K — up 71% from $2.46K a quarter earlier.

Fund positioning in NYMX was balanced in Q2 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Nymox Pharmaceutical Corp (NYMX) as of Q2 2026, unchanged from Q1 2026.
  • Funds reported $4.21K of Nymox Pharmaceutical Corp stock for Q2 2026, up 71% quarter-over-quarter.
  • 0 funds opened new Nymox Pharmaceutical Corp positions in Q2 2026 and 0 closed out.

Based on aggregated 13F filings for Q2 2026.